Active Stocks: Apple Inc. (NASDAQ:AAPL), Immune Pharmaceuticals (NASDAQ:IMNP), Pacific Mercantile Bancorp (NASDAQ:PMBC), Xcel Energy Inc. (NYSE:XEL), Bio-Rad Laboratories (NYSE:BIO)

On Thursday shares of Apple Inc. (NASDAQ:AAPL) closed at $125.26. Company’s sales growth for last 5 years was 33.60% and EPS growth for next 5 years is recorded as 13.20%. Apple Inc. (NASDAQ:AAPL) announced that it will return an additional $50 billion to shareholders through a combination of dividends and stock buybacks. Apple now plans to return $200 billion of cash to investors by March 2017.

Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) in last trading activity advanced 5.97% to close at $1.98. Company weekly performance is 5.97% while its quarterly performance stands at 13.23%. Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) is -53.37% away from its 52 week high. Immune Pharmaceuticals Inc. (NASDAQ:IMNP) and Merrimack Pharmaceuticals announced on 4 May, that they are entering into a strategic partnership to accelerate the development of NanomAbs, a new generation of Antibody Nanoparticle Conjugates allowing the targeted delivery of chemo-therapeutics.

On last trading day Pacific Mercantile Bancorp (NASDAQ:PMBC) decreased -0.56% to close at $7.15. Its volatility for the week is 1.95% while volatility for the month is 1.87%. PMBC’s sales growth for past 5 years was -5.80% and its EPS growth for past 5 years was 41.90%. Pacific Mercantile Bancorp (NASDAQ:PMBC) monthly performance is -2.05%. TheStreet upgraded shares of Pacific Mercantile Bancorp (NASDAQ:PMBC) from a hold rating to a buy rating in a report.

Xcel Energy Inc. (NYSE:XEL) has 0.20% insider ownership while its institutional ownership stands at 69.80%. In last trading activity company’s stock closed at $33.48. On 4 May, Xcel Energy Inc. (NYSE:XEL) has decided to “buy” an unfinished 100-turbine farm near Jamestown, instead of just buying power from the turbines.

On last trading day Bio-Rad Laboratories, Inc. (NYSE:BIO) decreased -0.78% to close at $141.87. Its volatility for the week is 2.66% while volatility for the month is 1.56%. BIO’s sales growth for past 5 years was 4.00% and its EPS growth for past 5 years was -10.10%. Bio-Rad Laboratories, Inc. (NYSE:BIO) monthly performance is 2.67%. Bio-Rad Laboratories, Inc. (NYSE:BIO) announced the launch of two PrimePCR™ Assay Kits for Droplet Digital PCR (ddPCR™) (ddPCR™). This release expands Bio-Rad’s offering of predesigned, fully wet-lab validated assays with kits for SMN1 and SMN2 copy number determination. These targets are commonly studied genes associated with Spinal Muscular Atrophy (SMA).

Leave a Reply

Your email address will not be published. Required fields are marked *